TL;DR
Get health and wellness essentials delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
A MedPage Today opinion article by Hana Kahleova argues that routine antibiotic use in food animals contributes to resistance later seen in human infections. It points to China’s 2017 ban on colistin as a feed additive and subsequent declines in resistance as evidence that policy can affect resistance levels, while calling for reduced routine use and changes in food purchasing.
A MedPage Today opinion article published October 4 argues that efforts to address drug-resistant infections should look beyond prescriptions in clinics and hospitals to routine antibiotic use in food animals. Physician Hana Kahleova points to China’s restriction on colistin use as a feed additive and subsequent declines in resistance as an example of how agricultural policy can affect drugs used to treat people.
Kahleova writes that roughly 70% of antibiotics considered important to human medicine in the United States are sold for use in food animals. She says much of that use is not to treat sick animals, but to prevent disease or support production in intensive farming systems. The article’s central argument is that clinical stewardship cannot address the full problem if substantial antibiotic use occurs outside the health-care system.
The author describes several possible routes for resistant bacteria and resistance genes to reach people, including meat, water, dust, farm workers and manure. She cites estimates that drug-resistant infections kill about 35,000 people a year in the United States and a Lancet forecast of roughly 39 million deaths worldwide from resistant infections between now and 2050. These are figures reported in the opinion piece, not new estimates produced by MedPage Today in the article.
As a policy example, Kahleova discusses mcr-1, a transferable gene associated with resistance to colistin, a drug used as a last-resort treatment for some infections. She says the gene spread internationally after colistin was used as a growth promoter on Chinese pig farms, and that resistance declined in animals and people after China banned colistin as a feed additive in 2017. The piece characterizes that sequence as evidence that changing agricultural use can help preserve the effectiveness of a medicine.
Why Farm Antibiotic Use Matters
The issue matters because resistance can limit treatment choices when an infection does not respond to commonly used drugs. Hospitals and clinicians can improve prescribing practices, but the article argues that these steps address only antibiotic use within medicine, not use across food production. The source’s point is not that every resistant infection comes from a farm, but that agricultural use is a major part of the wider environment in which resistance develops and spreads.
Kahleova says clinicians and institutions have some options alongside policy advocacy: discuss more plant-forward diets when relevant to a patient’s care, review food-service purchasing, and ask professional societies to support limits on routine preventive use in healthy animals. These actions are presented as complementary measures, not substitutes for treating sick livestock or for government policy. The scale of their effect is not quantified in the article.
As an affiliate, we earn on qualifying purchases.
The Colistin Policy Example
The opinion piece distinguishes between routine preventive antibiotic use in animals that are not ill and veterinary treatment for animals that are sick. Kahleova cites the World Health Organization’s call to stop routine preventive use in healthy animals, while stressing that the proposal is not to eliminate veterinary antibiotics altogether.
Colistin illustrates why that distinction can matter. The drug is held in reserve for difficult human infections, and the article links its agricultural use in China to the emergence and international spread of mcr-1. After China prohibited colistin as a feed additive in 2017, resistance levels reportedly fell in animals and people. The article uses that change as a policy example; it does not provide a detailed account of the underlying studies or their methods.
Limits of the Evidence Presented
The source is an opinion article, not a new research study or an official policy announcement. It cites national and global estimates and describes the colistin example, but does not lay out the study designs, data sources or uncertainties behind those figures. The article also does not quantify how much resistance in a particular patient or infection can be traced to food-animal use.
It remains unclear from the supplied material how proposed changes to diets or institutional food purchasing would affect antibiotic use or resistance at scale. Nor does the article specify whether new regulations are under consideration or how current livestock use varies by drug, animal species or production system.
Policy and Purchasing Decisions
Kahleova urges clinicians to press for targeted farm-level policy through professional medical societies, while using counseling and institutional purchasing to address demand for animal products produced with routine antibiotic use. The article does not announce a specific campaign, regulation or implementation deadline.
The next developments to watch are whether governments or agricultural authorities change rules on preventive antibiotic use, and whether health systems add food sourcing to stewardship discussions. Any assessment of results would need to track antibiotic use and resistance over time, while accounting for differences among drugs, farms and regions.
Key Questions
What is the main argument of the article?
It argues that antibiotic stewardship should include food-animal production, because clinical prescribing is only one source of antibiotic use that can contribute to resistance.
Does the article call for ending veterinary antibiotics?
No. Kahleova says sick animals still need treatment. The call is to stop routine preventive use in animals that are not sick, consistent with the targeted approach she attributes to the World Health Organization.
What happened with colistin in China?
The article says China banned colistin as a feed additive in 2017 and that resistance subsequently fell in animals and people. It presents this as a policy example, though the supplied text does not detail the studies behind the finding.
Can food choices reduce antibiotic resistance?
Kahleova argues that lower demand for meat produced in systems reliant on routine antibiotic use could reduce pressure to use those drugs. The article does not quantify the effect of individual diet choices or institutional purchasing on resistance.
How much antibiotic use in the United States is for food animals?
The opinion piece states that about 70% of antibiotics important to human medicine in the United States are sold for use in food animals. The supplied source does not provide a breakdown by drug or animal type.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
